Human Tissue Factor Pathway Inhibitor (TFPI) AssayMax™ELISA KitHuman Tissue Factor Pathway Inhibitor (TFPI) AssayMax™ELISA Kit
Move your mouse over image or click to enlarge

Human Tissue Factor Pathway Inhibitor (TFPI) AssayMax™ELISA Kit

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.

Cat# Size Price Qty Buy
ET1005-1 96 Well Plate £276.25

Additional Information

Property Value or Rating
Manufacturer Assaypro, LLC.
Product Type AssayMax™ ELISA Kits
Samples Serum, Milk, Cell Culture, CSF
Species Human
Reactivity Human
Assay Format Sandwich ELISA
Product Size 96 Well Plate
Range 0.156-10 ng/ml
Plex Number 1
Storage Refer to component labels for details
Entrez Gene 7035
Omim 152310
UniProt P10646
UniGene Hs.516578
Special Notes For Research Use Only, Not To Be Used For Diagnostic Purposes
References * Schernthaner GH et al. (2006) No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest 36(5):333-339 
* Mousa SA et al. (2007) Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects. J Clin Pharmacol. 47(12):1508-20 
* Wang JS et al. (2007) Exercise Modulates Platelet-Nasopharyngeal Carcinoma Cell Aggregation and Subsequent Tissue Factor and Matrix Metalloproteinase Activities. J Appl Physiol 149(4):187-195 
* Teng YC et al. (2009) Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J. Perinat. Med. 37:343-348 
* Xiong Y et al. (2011) Alternations of Maternal and Cord Plasma Hemostasis in Preeclampsia Before and After Delivery. Hypertens Pregnancy. 30(3):347-358 
* Sosothikul D et al. (2012) Reference values for thrombotic markers in children. Blood Coagul Fibrinolysis. 23(3):208-11. 
* Varadi K et al. (2016) Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA 

" title="

* Schernthaner GH et al. (2006) No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest 36(5):333-339 
* Mousa SA et al. (2007) Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects. J Clin Pharmacol. 47(12):1508-20 
* Wang JS et al. (2007) Exercise Modulates Platelet-Nasopharyngeal Carcinoma Cell Aggregation and Subsequent Tissue Factor and Matrix Metalloproteinase Activities. J Appl Physiol 149(4):187-195 
* Teng YC et al. (2009) Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J. Perinat. Med. 37:343-348 
* Xiong Y et al. (2011) Alternations of Maternal and Cord Plasma Hemostasis in Preeclampsia Before and After Delivery. Hypertens Pregnancy. 30(3):347-358 
* Sosothikul D et al. (2012) Reference values for thrombotic markers in children. Blood Coagul Fibrinolysis. 23(3):208-11. 
* Varadi K et al. (2016) Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA 

" target="_blank">

* Schernthaner GH et al. (2006) No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest 36(5):333-339 
* Mousa SA et al. (2007) Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects. J Clin Pharmacol. 47(12):1508-20 
* Wang JS et al. (2007) Exercise Modulates Platelet-Nasopharyngeal Carcinoma Cell Aggregation and Subsequent Tissue Factor and Matrix Metalloproteinase Activities. J Appl Physiol 149(4):187-195 
* Teng YC et al. (2009) Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J. Perinat. Med. 37:343-348 
* Xiong Y et al. (2011) Alternations of Maternal and Cord Plasma Hemostasis in Preeclampsia Before and After Delivery. Hypertens Pregnancy. 30(3):347-358 
* Sosothikul D et al. (2012) Reference values for thrombotic markers in children. Blood Coagul Fibrinolysis. 23(3):208-11. 
* Varadi K et al. (2016) Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA 

Related Documents